Execution of Optimization Initiatives Leads to Material Improvement in FY 2023 Operating Loss and Modified EBITDA
Q4 2023 Financial Highlights (vs. Q4 2022):
- Net sales were
$11.7 million compared to$15.0 million . - Gross profit was
$0.5 million compared to$3.4 million , with gross margin of 4.0% compared to 22.9%. - Adjusted gross profit, which excludes non-cash inventory adjustments and a one-time change to policy for discounts, increased 26% to
$4.3 million with gross margin of 34.9%. - Delivery and handling costs were reduced by 32% to
$2.82 per case. - Selling, general and administrative expenses were reduced by 23% to
$3.0 million . - Operating loss was
$5.0 million compared to$3.7 million . - Modified EBITDA improved to
$43,000 compared to$(2.8) million .
FY 2023 Financial Highlights (vs. FY 2022):
- Net sales were
$44.7 million compared to$53.0 million . - Gross profit was
$9.7 million compared to$12.1 million , with gross margin of 21.7% compared to 22.8%. - Adjusted gross profit, which excludes non-cash inventory adjustments and a one-time change to policy for discounts, increased 12% to
$13.6 million with gross margin of 29.9%. - Delivery and handling costs were reduced by 35% to
$3.07 per case. - Selling, general and administrative expenses were reduced by 26% to
$11.0 million . - Operating loss improved to
$9.4 million compared to$14.8 million . - Modified EBITDA improved to
$(3.7) million compared to$(13.1) million .
Management Commentary
“I am proud of our team’s hard work in 2023 as they executed on our strategic initiatives to consistently lower input costs and optimize our cost structure, resulting in more than
“Looking ahead, we have several key initiatives to drive growth and profitability. As we build our inventory levels, we will sharpen our focus on returning to growth through our key product categories: Reed’s
Fourth Quarter 2023 Financial Results
During the fourth quarter of 2023, net sales were
Gross profit for the fourth quarter of 2023 was
Delivery and handling costs were reduced by 32% to
Selling, general and administrative costs declined by 23% to
Operating loss during the fourth quarter of 2023 was
Modified EBITDA improved to
Update on Recent Financing
During the first quarter of 2024, Reed’s closed on a
Liquidity and Cash Flow
For the fourth quarter of 2023, cash used in operations was
As of
FY 2024 Financial Outlook
The Company projects net sales growth, gross margin expansion, and to achieve modified EBITDA profitability for the full year 2024. Reed’s also expects to generate positive cash flow from operations for the full year 2024.
Conference Call
The Company will conduct a conference call today,
Reed’s management will host the conference call, followed by a question-and-answer period.
Date:
Time:
Toll-free dial-in number: (844) 850-0544
International dial-in number: (412) 542-4115
Conference ID: 10187056
Webcast: Reed’s Q4 & FY 2023 Conference Call
Please dial into the conference call 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact the company’s investor relations team at (720) 330-2829.
The conference call will also be broadcast live and available for replay on the investor relations section of the Company’s website at https://investor.reedsinc.com.
About
Reed’s is an innovative company and category leader that provides the world with high quality, premium and naturally bold™ better-for-you beverages. Established in 1989, Reed's is a leader in craft beverages under the Reed’s®, Virgil’s® and Flying Cauldron® brand names. The Company’s beverages are now sold in over 45,000 stores nationwide.
Reed’s is known as America's #1 name in natural, ginger-based beverages. Crafted using real ginger and premium ingredients, Reed’s portfolio includes ginger beers, ginger ales, ready-to-drink ginger mules and hard ginger ales. The brand has recently successfully expanded into the zero-sugar segment with its proprietary, natural sweetener system.
Virgil's® is an award-winning line of craft sodas, made with the finest natural ingredients and without GMOs or artificial preservatives. The brand offers an array of great tasting, bold flavored sodas including Root Beer,
Flying Cauldron® is a non-alcoholic butterscotch beer prized for its creamy vanilla and butterscotch flavors. Sought after by beverage aficionados, Flying Cauldron is made with natural ingredients and no artificial flavors, sweeteners, preservatives, gluten, caffeine, or GMOs.
For more information, visit drinkreeds.com, virgils.com and flyingcauldron.com. To receive exclusive perks for Reed’s investors, please visit the Company’s page on the Stockperks app here.
Forward-Looking Statements
Statements in this release that are not historical are forward-looking statements made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are typically identified by terms such as "estimate," "expect,” “intend,” "project," "will," “plan,” and similar expressions. These forward-looking statements are based on current expectations and include our management’s expectations and guidance for fiscal year 2024 under the heading “FY 2024 Financial Outlook”. The achievement or success of the matters covered by such forward-looking statements involves risks, uncertainties, and assumptions, many of which involve factors or circumstances that are beyond our control. Reed‘s 2024 guidance reflects year-to-date and expected future business trends and includes impacts of the inventory shortage as of the date hereof. New supply chain challenges that may develop and further potential inflation cannot be reasonably estimated and are not factored into current fiscal 2024 guidance. These risks could materially impact our ability to access raw materials, production, transportation and/or other logistics needs.
Financial guidance should not be viewed as a substitute for full financial statements prepared in accordance with GAAP.
If any such risks or uncertainties materialize or if any of the assumptions prove incorrect, Reed’s actual results could differ materially from the results expressed or implied by the forward-looking statements we make, including our ability to achieve our targets for the fiscal year ending
Investor Relations Contact
Elevate IR
ir@reedsinc.com
(720) 330-2829
REED’S, INC. | |||||||||||||||||
STATEMENTS OF OPERATIONS | |||||||||||||||||
For the Years Ended | |||||||||||||||||
(Amounts in thousands, except share and per share amounts) | |||||||||||||||||
Three Months Ended | Year Ended | ||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||
$ | 11,693 | $ | 15,040 | $ | 44,711 | $ | 53,041 | ||||||||||
Cost of goods sold | 8,106 | 11,594 | 31,884 | 40,929 | |||||||||||||
Inventory write-offs associated with exited categories and major packaging and formula changes | 1,848 | 0 | 1,848 | ||||||||||||||
Provision for product hold | 1,267 | - | 1,267 | - | |||||||||||||
Gross profit | 472 | 3,446 | 9,712 | 12,112 | |||||||||||||
Operating expenses: | |||||||||||||||||
Delivery and handling expense | 1,847 | 2,710 | 7,561 | 11,603 | |||||||||||||
Selling and marketing expense | 1,298 | 1,693 | 4,865 | 7,316 | |||||||||||||
General and administrative expense | 1,691 | 2,170 | 6,118 | 7,489 | |||||||||||||
Provision for receivable with former related party | 585 | 538 | 585 | 538 | |||||||||||||
Total operating expenses | 5,421 | 7,111 | 19,129 | 26,946 | |||||||||||||
Loss from operations | (4,949 | ) | (3,665 | ) | (9,417 | ) | (14,834 | ) | |||||||||
Interest expense | (1,647 | ) | (3,104 | ) | (6,106 | ) | (5,223 | ) | |||||||||
Net loss | (6,596 | ) | (6,769 | ) | (15,523 | ) | (20,057 | ) | |||||||||
Dividends on Series A Convertible Preferred Stock | - | - | (5 | ) | (5 | ) | |||||||||||
Net loss attributable to common stockholders | $ | (6,596 | ) | $ | (6,769 | ) | $ | (15,528 | ) | $ | (20,062 | ) | |||||
Loss per share – basic and diluted | $ | (2.07 | ) | $ | (2.84 | ) | $ | (4.39 | ) | $ | (9.07 | ) | |||||
Weighted average number of shares outstanding – basic and diluted | 3,186,246 | 2,384,507 | 3,537,882 | 2,211,319 |
REED’S, INC, | ||||||||
BALANCE SHEETS | ||||||||
(Amounts in thousands, except share amounts) | ||||||||
2023 | 2022 | |||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash | $ | 603 | $ | 533 | ||||
Accounts receivable, net of allowance of | 4,788 | 5,671 | ||||||
Inventory, net | 11,300 | 16,175 | ||||||
Receivable from former related party | 259 | 777 | ||||||
Prepaid expenses and other current assets | 811 | 939 | ||||||
Total current assets | 17,761 | 24,095 | ||||||
Property and equipment, net of accumulated depreciation of | 493 | 766 | ||||||
Intangible assets | 629 | 626 | ||||||
Total assets | $ | 18,883 | $ | 25,487 | ||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 9,133 | $ | 9,805 | ||||
Accrued expenses | 1,096 | 233 | ||||||
Revolving line of credit, net of capitalized financing costs of | 9,758 | 10,974 | ||||||
Payable to former related party | 259 | 2,025 | ||||||
Current portion of convertible notes payable, net of debt discount of | 7,325 | 2,434 | ||||||
Current portion of lease liabilities | 207 | 187 | ||||||
Total current liabilities | 27,778 | 25,658 | ||||||
Convertible note payable, net of debt discount of | 10,286 | 8,092 | ||||||
Lease liabilities, less current portion | - | 207 | ||||||
Total liabilities | 38,064 | 33,957 | ||||||
Stockholders’ equity (deficit): | ||||||||
Series A Convertible Preferred stock, | 94 | 94 | ||||||
Common stock, | - | - | ||||||
Additional paid in capital | 119,452 | 114,635 | ||||||
Accumulated deficit | (138,727 | ) | (123,199 | ) | ||||
Total stockholders’ equity (deficit) | (19,181 | ) | (8,470 | ) | ||||
Total liabilities and stockholders’ equity (deficit) | $ | 18,883 | $ | 25,487 | ||||
REED’S, INC. | |||||||||||
STATEMENTS OF CASH FLOWS | |||||||||||
For the Years Ended | |||||||||||
(Amounts in thousands) | |||||||||||
2023 | 2022 | ||||||||||
Cash flows from operating activities: | |||||||||||
Net loss | $ | (15,523 | ) | $ | (20,057 | ) | |||||
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||||
Depreciation | 142 | 108 | |||||||||
Loss on disposal of property & equipment | 8 | - | |||||||||
Amortization of debt discount | 1,137 | 530 | |||||||||
Amortization of prepaid financing costs | - | 431 | |||||||||
Fair value of vested options | 490 | 701 | |||||||||
Fair value of vested restricted shares granted to directors and officers for services | 3 | 158 | |||||||||
Common shares issued as financing costs | 37 | ||||||||||
Common shares issued for compensation | 36 | - | |||||||||
Provision for product hold | 1,267 | - | |||||||||
Change in allowance for doubtful accounts | 608 | 37 | |||||||||
Provision for receivable with former related party | 585 | 538 | |||||||||
Change in inventory reserve | 955 | 344 | |||||||||
Accrued interest on convertible note | 2,831 | 2,313 | |||||||||
Lease liability | -187 | -161 | |||||||||
Changes in operating assets and liabilities: | |||||||||||
Accounts receivable | 275 | -525 | |||||||||
Inventory | 2,653 | 531 | |||||||||
Prepaid expenses and other assets | 528 | 55 | |||||||||
Decrease in right of use assets | 140 | 117 | |||||||||
Accounts payable | -1073 | -629 | |||||||||
Accrued expenses | 859 | -58 | |||||||||
Net cash used in operating activities | (4,266 | ) | (15,530 | ) | |||||||
Cash flows from investing activities: | |||||||||||
Intangible asset trademark costs | (3 | ) | (2 | ) | |||||||
Purchase of property and equipment | (85 | ) | - | ||||||||
Sale of property and equipment | 68 | - | |||||||||
Net cash used in investing activities | (20 | ) | (2 | ) | |||||||
Cash flows from financing activities: | |||||||||||
Proceeds from line of credit | 43,836 | 54,564 | |||||||||
Payments on the line of credit | (45,213 | ) | (53,456 | ) | |||||||
Payment of debt issuance costs | - | (483 | ) | ||||||||
Proceeds from sale of common stock | 4,016 | 5,034 | |||||||||
Proceeds from convertible note payable, net of expenses | 3,751 | 12,430 | |||||||||
Payment of convertible note payable | (200 | ) | (3,100 | ) | |||||||
Amounts from former related party, net | (1,833 | ) | 1,029 | ||||||||
Repurchase of common stock | (1 | ) | (2 | ) | |||||||
Net cash provided by financing activities | 4,356 | 16,016 | |||||||||
Net increase in cash | 70 | 484 | |||||||||
Cash at beginning of period | 533 | 49 | |||||||||
Cash at end of period | $ | 603 | $ | 533 | |||||||
Supplemental disclosures of cash flow information: | |||||||||||
Cash paid for interest | $ | 1,046 | $ | 1,911 | |||||||
Non-cash investing and financing activities: | |||||||||||
Dividends on Series A Convertible Preferred Stock | $ | 5 | $ | 5 | |||||||
Common Shares issued for financing costs | $ | 273 | - | ||||||||
Common Shares issued for principal payment | $ | - | $ | 200 | |||||||
Common Shares issued for interest payment | $ | - | $ | 1,261 |
Modified EBITDA
In addition to our GAAP results, we present Modified EBITDA as a supplemental measure of our performance. However, Modified EBITDA is not a recognized measurement under GAAP and should not be considered as an alternative to net income, income from operations or any other performance measure derived in accordance with GAAP, or as an alternative to cash flow from operating activities as a measure of liquidity. We define Modified EBITDA as net income (loss), plus interest expense, tax expense, depreciation and amortization, stock-based compensation, changes in fair value of warrant expense, legal and insurance settlements, inventory write-offs associated with exited categories and major packaging and formula changes, one-time changes to policy, impact of changes to accounting methodology and one-time restructuring-related costs including employee severance and asset impairment.
Management considers our core operating performance to be that which our managers can affect in any particular period through their management of the resources that affect our underlying revenue and profit generating operations during that period. Non-GAAP adjustments to our results prepared in accordance with GAAP are itemized below. You are encouraged to evaluate these adjustments and the reasons we consider them appropriate for supplemental analysis. In evaluating Modified EBITDA, you should be aware that in the future we may incur expenses that are the same as or similar to some of the adjustments in this presentation. Our presentation of Modified EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items.
Set forth below is a reconciliation of net loss to Modified EBITDA for the three and twelve months ended
Year Ended | ||||||||||
2023 | 2022 | |||||||||
Net loss | $ | (15,523 | ) | $ | (20,057 | ) | ||||
Modified EBITDA adjustments: | ||||||||||
Depreciation and amortization | 281 | 225 | ||||||||
Interest expense | 6,106 | 5,223 | ||||||||
Tax expense | 251 | |||||||||
Stock option and other noncash compensation | 493 | 859 | ||||||||
Provision for product hold | 1,267 | |||||||||
Provision for receivable with former related party | 585 | 538 | ||||||||
Inventory write-offs associated with exited categories and major packaging and formula changes | 1,848 | |||||||||
One time change to policy for discounts | 756 | |||||||||
Legal settlement | 12 | |||||||||
Severance costs | 256 | 66 | ||||||||
Total EBITDA adjustments | $ | 11,855 | $ | 6,911 | ||||||
Modified EBITDA | $ | (3,668 | ) | $ | (13,146 | ) | ||||
Three months Ended | ||||||||||
2023 | 2022 | |||||||||
Net loss | $ | (6,596 | ) | $ | (6,769 | ) | ||||
Modified EBITDA adjustments: | ||||||||||
Depreciation and amortization | 67 | 60 | ||||||||
Interest expense | 1,647 | 3,104 | ||||||||
Tax expense | 251 | 0 | ||||||||
Stock option and other noncash compensation | 139 | 274 | ||||||||
Provision for product hold | 1,267 | |||||||||
Provision for receivable with former related party | 585 | 538 | ||||||||
Inventory write-offs associated with exited categories and major packaging and formula changes | 1,848 | |||||||||
One time change to policy for discounts | 756 | |||||||||
Legal settlement | 0 | |||||||||
Severance costs | 79 | |||||||||
Total EBITDA adjustments | $ | 6,639 | $ | 3,976 | ||||||
Modified EBITDA | $ | 43 | $ | (2,793 | ) | |||||
We present Modified EBITDA because we believe it assists investors and analysts in comparing our performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. In addition, we use Modified EBITDA in developing our internal budgets, forecasts, and strategic plan; in analyzing the effectiveness of our business strategies in evaluating potential acquisitions; making compensation decisions; and in communications with our board of directors concerning our financial performance. Modified EBITDA has limitations as an analytical tool, which includes, among others, the following:
- Modified EBITDA does not reflect our cash expenditures, or future requirements, for capital expenditures or contractual commitments;
- Modified EBITDA does not reflect changes in, or cash requirements for, our working capital needs;
- Modified EBITDA does not reflect future interest expense, or the cash requirements necessary to service interest or principal payments, on our debts; and
- Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and Modified EBITDA does not reflect any cash requirements for such replacements.
Source:
2024 GlobeNewswire, Inc., source